Harry J. Leonhardt, Esq.

General Counsel, Chief Compliance Officer, and Corporate Secretary

Mr. Leonhardt serves as Poseida’s General Counsel, Chief Compliance Officer and Corporate Secretary. He has extensive legal expertise and executive management experience in the biopharmaceutical industry. Most recently, Mr. Leonhardt served as Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary and a member of the executive committee for Halozyme Therapeutics, Inc. where he provided strategic counsel on a broad range of legal matters for the company and its board of directors. Prior to Halozyme, Mr. Leonhardt served as Senior Vice President, Legal and Compliance & Corporate Secretary and as a member of the executive committee for Amylin Pharmaceuticals, which was acquired by Bristol-Myers Squibb in 2012. Prior to that time, Mr. Leonhardt served as General Counsel for a number of San Diego-based biotech companies, and as Chief Litigation Counsel and later as General Counsel for the European Region at Allergan Pharmaceuticals. He received his J.D. from the University of Southern California Law Center in Los Angeles and B.Sc. from the University of Sciences in Philadelphia.